Phosphoinositide 3-kinase-delta could be a biomarker for eosinophilic nasal polyps

Sci Rep. 2018 Oct 30;8(1):15990. doi: 10.1038/s41598-018-34345-3.

Abstract

Nasal polyps (NP) cause diverse clinical symptoms of chronic rhinosinusitis (CRS). Chronic inflammation of sinonasal mucosa is known to be crucial in NP formation. We aimed to define the implications of phosphoinositide 3-kinase (PI3K)-δ in nasal inflammation associated with NP by analyzing NP tissue obtained from CRS patients. Results showed that expression of p110δ, a regulatory subunit of PI3K-δ, in NP tissue was increased compared to control tissue. Increased p110δ expression was closely correlated with more severe CRS features. Interestingly, p110δ expression was increased in eosinophilic NP, which are closely related to more complicated clinical courses of the disease. Furthermore, CRS patients possessing NP with higher p110δ expression displayed more eosinophils in NP tissue and blood, higher levels of IL-5 in NP tissue, and more severe features of the disease. Therefore, PI3K-δ may contribute to the formation of NP, especially eosinophilic NP associated with more severe clinical presentations and radiological features.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers
  • Chronic Disease
  • Class I Phosphatidylinositol 3-Kinases / metabolism*
  • Eosinophils / pathology*
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Male
  • Middle Aged
  • Nasal Polyps / diagnosis*
  • Nasal Polyps / etiology
  • Nasal Polyps / metabolism*
  • Nasal Polyps / therapy
  • Severity of Illness Index
  • Signal Transduction
  • Young Adult

Substances

  • Biomarkers
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CD protein, human